Legend Biotech names Ingrid Zhang CEO

LEGN•2026-11-10

Legend Biotech appointed Ingrid Zhang CEO, effective September 15, 2026. She succeeds interim CEO Alan Bash, who resumed his role as president, CARVYKTI.

1. CEO appointment

Legend Biotech appointed Ingrid Zhang chief executive officer, effective September 15, 2026. Zhang succeeds Alan Bash, who had served as interim CEO since July 2026 and resumed his role as president, CARVYKTI.

Sources

Legend Biotech names Ingrid Zhang CEO

Sec

Legend Biotech names Ingrid Zhang CEO

1. CEO appointment

Related News

ABM expands Phoenix Suns, Mercury partnership with three-year agreement

UK one-year fixed savings rates rise to 4.46% in October, Clear Score analysis shows

Leverage Shares issues USD 19.5 million in exchange-traded notes

Sources

Legend Biotech names Ingrid Zhang CEO

Verisk Analytics: Raymond James raises target price to $245 from $230

SABESP fiscal council backs R$ 2.64 billion interest on equity payout